Siblings Books/Book Section [1/1] Conference Papers/Meeting Abstract [2/2] Patents [0/26] Collection Statistics Item counts issued in 3 years:16(19.75%) Items With Fulltext:80(98.77%) Download counts of the item Download times greater than 0:80(100.00%) Download times greater than 100:77(96.25%) Total Bitstream Download Counts:43027(96.52%) Last Update: 2024-12-04 05:11 Top Upload Loading... Top Download Loading... Recent Submissions Boosting DNA vaccine power by lipid... Effect of C-type lectin 16 on dengu... SARS-CoV-2 spike-FLIPr fusion prote... Lipid nanoparticle-encapsulated DNA... Co-delivery of a trimeric spike DNA... Mechanical transmission of dengue v... Recombinant lipidated FLIPr effecti... Omicron-specific mRNA vaccine induc... Formulation of SARS-CoV-2 spike pro... Glycosylation and S-palmitoylation ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 51-75 of 81. (4 Page(s) Totally) << < 1 2 3 4 > >> View [10|25|50] records per page

Date	Title	Relation
2014-01	The fate of regulatory T cells: Survival or apoptosis	Cellular and Molecular Immunology. 2014 Jan;11(1):11-13.
2013-09-19	Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement	PLoS Neglected Tropical Diseases. 2013 Sep 19;7(9):Article number e2432.
2013-09	Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III	Microbes and Infection. 2013 Sep;15(10-11):719-728.
2013-07	A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates	Archives of Virology. 2013 Jul;158(7):1523-1531.
2013-05	Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines	Journal of Immunology. 2013 May;190(10):5065-5077.
2013-01	Mesenchymal stem cells promote neutrophil activation by inducing IL-17 production in CD4+ CD45RO+ T cells	Immunobiology. 2013 Jan;218(1):90-95.
2012-08	CD4+ T cells disarm or delete cytotoxic T lymphocytes under IL-17–Polarizing conditions	Journal of Immunology. 2012 Aug;189(4):1671-1679.
2012-05	Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses	PLoS Neglected Tropical Diseases. 2012 May;6(5):Article number e1645.
2012-04	A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo	Journal of Immunotherapy. 2012 Apr;35(3):235-244.
2011-08	A novel single-dose dengue subunit vaccine induces memory immune responses	PLoS ONE. 2011 Aug;6(8):Article number e23319.
2011-04	Increased expression of IL-21 reduces tumor growth by modulating the status of tumor-infiltrated lymphocytes	Immunobiology. 2011 Apr;216(4):491-496.
2010-08	Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice	PLoS ONE. 2010 Aug;5(8):Article number e12279.
2010-07	A recombinant lipoprotein containing an unsaturated fatty acid activates NF-kappaB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide	Molecular Immunology. 2010 Jul;47(11-12):2015-2021.
2010-06	IL-6-transfected tumor cells modulate the status of CD8+ and CD4+ T cells to control tumor growth	Immunobiology. 2010 Jun;215(6):486-491.
2010-02	Highly sensitive rare cell detection based on quantum dot probe fluorescence analysis	Analytical and Bioanalytical Chemistry. 2010 Feb;396(3):1135-1141.
2009-11-01	Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization	Cancer Biology and Therapy. 2009 Nov 1;8(21):2025-2032.
2009-08	Formulation and immunological evaluation of novel vaccine delivery systems based on bioresorbable poly(ethylene glycol)-block-poly(lactide-co-epsilon-caprolactone)	Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2009 Aug;90(2):832-841.
2009-08	Development of multi-phase emulsions based on bioresorbable polymers and oily adjuvant	Pharmaceutical Research. 2009 Aug;26(8):1856-1862.
2009-05-22	Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus	Biochemical and Biophysical Research Communications. 2009 May 22;383(1):27-31.
2009-05	Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine	Microbes and Infection. 2009 May;11(6-7):654-660.
2009-02-25	A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design	Vaccine. 2009 Feb 25;27(9):1400-1409.
2009-02	A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity	Microbes and Infection. 2009 Feb;11(2):288-295.
2007-08-01	Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6	Journal of Leukocyte Biology. 2007 Aug;82(2):354-360.
2007-07-06	Identification of synthetic vaccine candidates against SARS CoV infection	Biochemical and Biophysical Research Communications. 2007 Jul;358(3):716-721.
2007-03	The development and application of HLA tetramers in the detection, characterization and therapy of type 1 diabetes mellitus	Review of Diabetic Studies. 2007 Mar;4(1):56-61.

Showing items 51-75 of 81. (4 Page(s) Totally) << < 1 2 3 4 > >> View [10|25|50] records per page